Nephrology Dialysis Transplantation Role of polyol pathway in nonenzymatic glycation
暂无分享,去创建一个
N. Hotta | S. Horiuchi | Y. Hamada | N. Araki
[1] M. Oka,et al. Aldose Reductase Inhibitors , 2001, Journal of enzyme inhibition.
[2] M. Cotter,et al. The relationship of vascular changes to metabolic factors in diabetes mellitus and their role in the development of peripheral nerve complications. , 1994, Diabetes/metabolism reviews.
[3] J. Nyengaard,et al. Hyperglycemic Pseudohypoxia and Diabetic Complications , 1993, Diabetes.
[4] T. Brown,et al. Detection of fructose-3-phosphokinase activity in intact mammalian lenses by 31P NMR spectroscopy. , 1993, The Journal of biological chemistry.
[5] M. Brownlee,et al. Glycation Products and the Pathogenesis of Diabetic Complications , 1992, Diabetes Care.
[6] T. Brown,et al. Fructose metabolism in the human erythrocyte. Phosphorylation to fructose 3-phosphate. , 1992, The Biochemical journal.
[7] S. Yagihashi,et al. Effect of Aminoguanidine on Functional and Structural Abnormalities in Peripheral Nerve of STZ-Induced Diabetic Rats , 1992, Diabetes.
[8] H. Hammes,et al. Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[9] G. Jerums,et al. Retardation by Aminoguanidine of Development of Albuminuria, Mesangial Expansion, and Tissue Fluorescence in Streptozocin-Induced Diabetic Rat , 1991, Diabetes.
[10] Y. Morino,et al. Immunochemical approach to characterize advanced glycation end products of the Maillard reaction. Evidence for the presence of a common structure. , 1991, The Journal of biological chemistry.
[11] T. Brown,et al. Identification of sorbitol 3-phosphate and fructose 3-phosphate in normal and diabetic human erythrocytes. , 1990, The Journal of biological chemistry.
[12] T. Brown,et al. Identification of fructose 3-phosphate in the lens of diabetic rats. , 1990, Science.
[13] A. Oronsky,et al. Administration of an aldose reductase inhibitor induces a decrease of collagen fluorescence in diabetic rats. , 1988, The Journal of clinical investigation.
[14] P. Raskin,et al. Aldose reductase inhibitors and diabetic complications. , 1987, The American journal of medicine.
[15] D. Greene,et al. Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications. , 1987, The New England journal of medicine.
[16] N. Hotta,et al. Effects of a fructose-rich diet and the aldose reductase inhibitor, ONO-2235, on the development of diabetic neuropathy in streptozotocin-treated rats , 1985, Diabetologia.
[17] A. Cerami,et al. Nonenzymatic glycosylation and the pathogenesis of diabetic complications. , 1984, Annals of internal medicine.
[18] J. Kinoshita,et al. Osmotic Changes caused by the Accumulation of Dulcitol in the Lenses of Rats fed with Galactose , 1962, Nature.
[19] H. Kato,et al. 3-Deoxyglucosone, an intermediate product of the Maillard reaction. , 1989, Progress in clinical and biological research.